Lestaurtinib Has the Potential to Inhibit the Proliferation of Hepatocellular Carcinoma Uncovered by Bioinformatics Analysis and Pharmacological Experiments

Patients diagnosed with hepatocellular carcinoma (HCC) seek a satisfactory prognosis. However, most HCC patients present a risk of recurrence, thus highlighting the lack of effectiveness of current treatments and the urgent need for improved treatment options. The purpose of this study was to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shuang, Liu, Shihai, Li, Yan, Liu, Changchang, Pan, Huazheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136166/
https://www.ncbi.nlm.nih.gov/pubmed/35646925
http://dx.doi.org/10.3389/fcell.2022.837428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136166/
https://www.ncbi.nlm.nih.gov/pubmed/35646925
http://dx.doi.org/10.3389/fcell.2022.837428

Ejemplares similares